Archives

ARTICLES FROM 2007

• Determining the Cost-Effectiveness of Neovascular AMD Treatments

  Jointly sponsored by The Dulaney Foundation and Retina Today Release Date: April 2007. Expiration Date: April 30, 2008. This continuing medical education activity is supported by an educational grant from Genentech.

  by MELISSA M. BROWN, MD, MN, MBA

• New Developments in the Transscleral Delivery of Ophthalmic Agents

  The profile of the drug being delivered is as important as the delivery method.

  by KARL G. CSAKY, MD, PhD

• Is Diabetic Retinopathy an Independent Risk Factor For Ischemic Stroke?

  Diabetic retinopathy may help predict people who could require a more comprehensive assessment of their stroke risk.

  by TIEN Y. WONG, MD, PhD

• Combined PDT With Intravitreal Bevacizumab Useful for Neovascular AMD

  Further investigation with large, controlled trials is warranted.

  by MANDEEP S. DHALLA, MD, AND GAURAV K. SHAH, MD

• Genetic Testing Sheds Light on Degenerative Eye Disease

  The molecular definition of the genetic basis of disease provides a unique adjunct to the clinical care of patients with hereditary retinal degenerations.

  by RADHA AYYAGARI, PhD

▶